You are here

  • Home
  • Archive
  • Volume 3, Issue Suppl 2
  • Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: long-term follow-up of three randomized clinical trials

Article metrics

Article menu

Download PDFPDF

Poster Presentation
Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: long-term follow-up of three randomized clinical trials

 

Online download statistics by month:

Online download statistics by month: December 2019 to January 2026

AbstractFullPdf
Dec 2019010
Jan 2020020
Feb 2020010
Apr 2020004
Jun 20200130
Jul 2020030
Sep 2020060
Nov 2020031
Dec 2020022
Jan 2021041
Mar 2021010
Apr 2021010
May 2021011
Jun 2021020
Jul 2021020
Sep 2021040
Oct 2021033
Nov 2021033
Dec 2021040
Jan 2022040
Feb 2022010
Mar 2022010
Apr 2022020
May 2022071
Jun 2022020
Jul 2022021
Aug 2022040
Sep 2022051
Oct 2022030
Nov 2022030
Dec 2022051
Jan 2023012
Feb 2023042
Mar 2023010
Apr 2023021
Jun 2023011
Jul 2023011
Oct 2023011
Nov 2023031
Dec 2023051
Jan 2024042
Feb 2024040
Mar 20240330
Apr 2024024
May 2024046
Jun 2024050
Jul 2024033
Aug 2024061
Sep 2024031
Oct 2024052
Nov 2024021
Dec 2024042
Jan 2025053
Feb 2025011
Mar 2025064
Apr 2025011
May 2025042
Jun 2025044
Dec 2025020
Jan 2026010
Total018396